A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol

Overview of attention for article published in BMC Cancer, February 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 33 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

PHARMACEUTICAL COMPOSITION

Application EP-3689376-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.